Journals / Ulusal Cerrahi Dergisi / 2009 / Cilt: 25 - Sayı: 4

Report of a case: Menetrier disease with severe hypoproteinemia and its surgical treatment

Ciddi hipoproteineminin eşlik ettiği Menetrier hastalığına ait bir olgu ve cerrahi tedavisi

Pages
174–177
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, total gastrectomy is still the most definitive treatment for Ménétrier's disease, especially for patients with uncontrollable severe protein loss.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ménétrier's disease is an uncommon condition of unknown aetiology.
📊
Key Findings & Data:A male with a diagnosis of Ménétrier disease with severe hypoproteinemia was operated.
💡
Conclusion & Impact:However, total gastrectomy is still the most definitive treatment for Ménétrier's disease, especially for patients with uncontrollable severe protein loss.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gastrit · hipertrofik · Hiperplazi

Abstract

Ménétrier's disease is an uncommon condition of unknown aetiology. It is characterized with giant hypertrophic mucosal folds of the stomach and associated with loss of protein from the mucosa. There is no enough data about genetic predisposition of Ménétrier disease. However, some paper regarding to familial occurence have been reported. We reported a case of Ménétrier disease with malnutrition and severe hypoproteinemia despite of treatment, its surgical treatment, and his sibling suggesting the possibility of genetic occurence for this condition. A male with a diagnosis of Ménétrier disease with severe hypoproteinemia was operated. Patient overcame some complications such as nasocomial pneumonia, hypoxic ischemic encephalopathy resulted in left monoparesis. He discharged from hospital after thirty days postoperatively. His son complaining some dispeptic symptoms performed gastroscopy and biopsises was diagnosed of mild hypertrophic gastritis, and is following for possibility of familial Ménétrier disease by periodical gastroscopy and biopsies. The risk of malignancy in Ménétrier disease is still controversial. However, total gastrectomy is still the most definitive treatment for Ménétrier's disease, especially for patients with uncontrollable severe protein loss.

Özet

Ménétrier hastalığı, mide mukozasında dev hipertrofik pililerle karakterize ve bu mukozadan protein kaybına bağlı gelişen hipoproteineminin de eşlik ettiği, midenin nadir görülen bir hastalığıdır. Hastalığı ilk olarak 1888'de, Fransız hekim Ménétrier “polyadenomes en nappe” olarak tanımlamıştır. O zamandan beri etyolojisi bilinmemekle beraber, cytomegalovirus (CMV) ve Helicobacter pylori infeksiyonlarının etkisini vurgulayan bazı yayınlar bulunmaktadır. Hastalığın klinik görünümü, endoskopik ve radyolojik bulguları maligniteye çok benzerdir. Hastalığın tanısını koydurucu belirlenmiş tanı kriterleri henüz yoktur. Bu nedenle hastalığın hipertrofik gastrit, mide lenfoması, mide karsinomu (linitis plastika) ile ayırıcı tanısının yapılması başlangıçta zordur. Kesin tanı ancak histopatolojik özelliklere göre konulur. Ménétrier hastalığının ailesel geçişi hakkında yeterli veriler olmamakla birlikte, hastalığın olası genetik predispozisyonu hakkında yayınlar mevcuttur. Bu yazıda, beslenme bozukluğu ve tedaviye rağmen ciddi hipoproteineminin eşlik ettiği bir Ménétrier olgusunu ve cerrahi tedavi sonuçlarını ve Ménétrier hastalığın ailesel geçişi hakkındaki düşüncelerimizi bildirmeyi amaçladık.

🔖

Cite This Article

GÜRBULAK, B., KABUL, E., BALIK, E., ÖZLÜK, Y. (2009). Report of a case: Menetrier disease with severe hypoproteinemia and its surgical treatment. Ulusal Cerrahi Dergisi, Cilt: 25 - Sayı: 4, 174–177. https://ajindex.com/articles/325514

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Green BT. Ménétrier's disease treated with octreotide long-acting release. Am Soc Gastrointest Endosc 2004;60:1028- 1029
  2. Kovacs AA, Churchill MA, Wood D, et al. Molecular and epidemiologic evaluations of a cluster of cases of Ménétrier's disease associated with cytomegalovirus. Pediatr Infect Dis J 1993;12:1011-1014
  3. Bayerdorffer E, Ritter MM, Hatz R, et al. Ménétrier's disease and Helicobacter pylori. N Engl J Med 1993;329-360
  4. Kim J, Cheong JH, Chen J, et al. Ménétrier's disease in Korea: Report of two cases and review of cases in a gastric cancer prevalent region. Yonsei Med J 2004:45; 555-560
  5. Scott HW, Shull HJ, Law DH, et al. Surgical management of Ménétrier's disease with protein-losing gastropathy. Ann Surg 1975; 181:765-776
  6. Frank BW, Kern F Jr. Ménétrier's Disease. Gastroenterology 1967;53:953-960
  7. Simson JNL, Jass JR, MacColl I. Ménétrier's disease and gastric carcinoma. J R Coll Surg Edinb 1987;32:134-136
  8. Fieber SS, Ricket RR. Hyperplastic gastropathy: analysis of 50 selected cases from 1955-1980. Am J Gastroenterol 1981;76:321-329
  9. Wood GM, Bates C, Brown RC, Losowsky MS. Intramucosal carcinoma of the gastric antrum complicating Ménétrier's disease. J Clin Pathol 1983;36: 1071-1075
  10. Scharschmidt BF. The natural history of hypertrophic gastropathy (Ménétrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med 1977;63:644-652
  11. Ibarrola C, Rodriguez-Pinilla M, Valino C, et al. An unusual expression of hyperplastic gastropathy (Ménétrier type) in twins. Eur J Gastroenterol Hepatol 2003; 15:441-445
  12. Larsen B, Tarp U, Kristensen E. Familial giant hypertrophic gastritis (Ménétrier's disease). Gut 1987;28:1517-1521
  13. Komorowski RA, Caya JG. Hyperplastic gastropathy. Clinicopathologic correlation. Am J Surg Pathol 1991;15:577-585.